Adaptive Biotechnologies T-Detect Lyme

Adaptive Biotechnologies has launched T-Detect Lyme, the second product in the company’s growing T-Detect immune testing franchise. Administered as a blood test, T-Detect Lyme identifies T cells activated by Borrelia burgdorferi, the bacterium that causes Lyme disease, to help diagnose early disease, the company said. The test is designed for adult patients demonstrating signs and symptoms including but not limited to the presence of an erythema migrans rash, fever, chills, headache, fatigue, muscle and joint aches, and swollen lymph nodes, according to the company. Adaptive said T-Detect Lyme is available to patients with a prescription through a qualified healthcare professional as a CLIA laboratory-developed test service.